Cargando…
Cell-Derived Vesicles for mRNA Delivery
The clinical translation of messenger mRNA (mRNA)-based therapeutics requires safe and effective delivery systems. Although considerable progress has been made on the development of mRNA delivery systems, many challenges, such as the dose-limiting toxicity and specific delivery to extrahepatic tissu...
Autores principales: | Li, Zhenghua, Liu, Zhen, Wu, Jiacai, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787719/ https://www.ncbi.nlm.nih.gov/pubmed/36559192 http://dx.doi.org/10.3390/pharmaceutics14122699 |
Ejemplares similares
-
Oral Delivery of mRNA Vaccine by Plant-Derived Extracellular Vesicle Carriers
por: Pomatto, Margherita A. C., et al.
Publicado: (2023) -
mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023) -
Lipid carriers for mRNA delivery
por: Zhang, Wanting, et al.
Publicado: (2023) -
Polyester materials for mRNA delivery
por: Chen, Wang, et al.
Publicado: (2022) -
Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment
por: Yang, Zheng, et al.
Publicado: (2023)